Open AccessBiologically equivalent substitutive technology: what is needed to manufacture pluripotent stem cells for next-generation platforms for discovery and therapy
Author(s) -
Paul A. De Sousa
Publication year - 2013
Publication title -
regenerative medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.572
H-Index - 63
eISSN - 1746-076X
pISSN - 1746-0751
DOI - 10.2217/rme.13.50
Subject(s) - regenerative medicine , induced pluripotent stem cell , drug discovery , stem cell , embryonic stem cell , engineering ethics , biology , computational biology , bioinformatics , microbiology and biotechnology , engineering , genetics , gene